
Intco Medical Technology Co., Ltd., headquartered in Zibo, Shandong, China,
PPE
Intco Medical Technology Co., Ltd., headquartered in Zibo, Shandong, China, is a world-leading manufacturer of disposable gloves and a premier provider of Personal Protective Equipment (PPE) solutions, listed on the Shenzhen Stock Exchange GEM (stock code: 300677). Its core business centers on the Personal Protective Equipment (PPE) sector, with hand protection as its absolute core—producing over 87 billion disposable gloves annually, including nitrile, PVC, and synthetic latex gloves. The company also offers protective gowns, respirators, face shields, and rehabilitation equipment. With Q1-Q3 2025 revenue of RMB 7.425 billion, Intco serves over 120 countries across eight major production bases in China and Vietnam. Leveraging proprietary third-generation fully automated production lines and advanced polymer modification technologies, it has built a vertically integrated manufacturing system from raw materials to finished products, solidifying its leadership in the global PPE market.
Strengths: Intco Medical's core strengths lie in its globally leading disposable glove capacity (87 billion/year) and proprietary third-generation dual-hand automated production lines, achieving industry-leading efficiency and formidable scale/cost advantages; vertical integration in nitrile latex modification ensures raw material self-sufficiency, strengthening profit margins; its Vietnam facility effectively mitigates U.S. tariff risks, with a global production footprint ensuring supply chain resilience.
Weaknesses: Intco Medical's main weaknesses include its heavy concentration in disposable gloves and PPE consumables, leading to a relatively narrow product mix vulnerable to supply-demand cycles and raw material price volatility; U.S. tariffs of up to 80% on Chinese-made nitrile gloves compress export profits, forcing market diversification; with over 80% of revenue from overseas, exchange rate fluctuations introduce significant uncertainty in foreign exchange gains/losses.Read More ▼Show Less ▲
Strengths: Intco Medical's core strengths lie in its globally leading disposable glove capacity (87 billion/year) and proprietary third-generation dual-hand automated production lines, achieving industry-leading efficiency and formidable scale/cost advantages; vertical integration in nitrile latex modification ensures raw material self-sufficiency, strengthening profit margins; its Vietnam facility effectively mitigates U.S. tariff risks, with a global production footprint ensuring supply chain resilience.
Weaknesses: Intco Medical's main weaknesses include its heavy concentration in disposable gloves and PPE consumables, leading to a relatively narrow product mix vulnerable to supply-demand cycles and raw material price volatility; U.S. tariffs of up to 80% on Chinese-made nitrile gloves compress export profits, forcing market diversification; with over 80% of revenue from overseas, exchange rate fluctuations introduce significant uncertainty in foreign exchange gains/losses.
Business Nature
Core Business Areas
Industry Rankings
Corporate Report
VerityRank Score
Based on market presence, financial scale, operational capacity, and brand strength.
Quick Facts
Headquarters
Zibo, Shandong, China
Founded
2009
Employees
11K+
Listing
Publicly Listed
Categories
Data Sources & Methodology
This corporate profile is compiled from publicly available sources including company annual reports, SEC/regulatory filings, official press releases, and verified third-party industry databases. Financial figures reflect the most recent fiscal year disclosures and are cross-validated across multiple independent references.
VerityRank Score is calculated using a proprietary multi-dimensional model evaluating market presence, financial strength, operational scale, innovation capacity, and brand influence. Individual dimension scores are normalized against industry peers and updated quarterly.
Disclaimer: This profile is for informational purposes only. VerityRank makes no warranties regarding completeness or timeliness. This content does not constitute investment advice or endorsement.
Key references: SZSE : 300677
